Skip to content

Acceptance of and Engagement with VitaLo

Acceptance of and Engagement with VitaLo - VitaLo

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00036305
Enrollment
20
Registered
2025-02-27
Start date
2025-03-21
Completion date
Unknown
Last updated
2025-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy adults

Interventions

Group 1: Healthy adults are recruited. After a baseline survey of primary and secondary patient-reported outcomes (e.g. well-being, body weight), participants receive access to the ChatBot-based lifes

Sponsors

Carl Gustav Carus Universitätsklinikum, Technische Universität Dresden
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: . Participant at least 18 years old · Capable of understanding and communicating in German · Participant willing to wear a wearable · Participant willing to use a ChatBot to track and communicate about their lifestyle · Participant with internet access and a computer and/or smartphone compatible with the ChatBot · Digital literacy to use a smartphone adequately and willingness to use it for their Well-being · Sufficient understanding of user interface (UI) of the Lifestyle-ChatBot · Participant willing and able to comply with all scheduled visits and other study procedures · Participant capable of giving personal informed consent

Exclusion criteria

Exclusion criteria: - Participant using other Apps or participating in other programs for improving their lifestyle · Participant with impairments – including mental or psychic impairments – or conditions which, in the opinion of the investigator, would seriously compromise the integrity of the study · Participant under 18 years of age · Participant using an insulin pump or continuous glucose monitoring (CGM)

Design outcomes

Primary

MeasureTime frame
Primary endpoints are the change in general well-being (measured with the Who-5 questionnaire) and physical activity (expressed as daily step count, measured via the Garmin Smartwatch) after 1 months of using VitaLo. For this the WHO-5 questionnaire will be accessed at baseline and after 30 days. The daily step count will be assessed continuously over the 30-days study period.

Secondary

MeasureTime frame
- acceptance and usability of the VitaLo measured with the user experience questionnaire (UEQ) and usage data of VitaLo further exploratory endpoints - lifestyle data generated by the GARMIN device (e.g. sleep data, heart frequency) - patient-reported outcomes like body weight, self-efficacy and physical activity questionnaire (Messung der Sport- und Bewegungsaktivität; BSA)

Countries

Germany

Contacts

Public ContactPeter Schwarz

Carl Gustav Carus Universitätsklinikum, Technische Universität Dresden

peter.schwarz@ukdd.de+493514582715

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026